Ilika (IKA)

Sector:

Electronic and Electrical Equipment

Index:

FTSE AIM All-Share

 28.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 60.00
  • 52 Week Low: 27.00
  • Currency: UK Pounds
  • Shares Issued: 158.98m
  • Volume: 51,260
  • Market Cap: £45.31m

Ilika launches tiny new solid-state battery for medical devices

By Josh White

Date: Wednesday 10 Apr 2019

LONDON (ShareCast) - (Sharecast News) - Solid-state battery technology company Ilika announced the launch of its 'Stereax M50' millimetre-scale solid-state batteries designed for medical implants.
The AIM-traded firm said the Stereax M50 took solid-state batteries to "a new level" of miniaturisation, which would enable medical device innovations that had previously been limited by the available battery technology.

It explained that the medical technology space was "one of the most challenging" environments for battery technologies, with batteries needing to be small enough to be unobtrusive, enabling implantable devices to be charged in a way that did not restrict a patient, and carrying as long a life-span as possible, avoiding the risks associated with repeated surgical procedures.

They also needed to be biocompatible, so that they did not pose a risk to the patient.

Ilika said each device application could require different capacities and form factors, which could now be accommodated with the customisable battery sizes and shapes enabled by the Stereax M50.

Innovation in applications that required injection into the bloodstream, monitoring heart rhythm or attachment onto the peripheral nervous system for neurostimulation could be enabled with the technology, the board said.

The batteries enabled self-sustaining power sources that did not need to be changed regularly, or use inconvenient cabling, it added.

"The implantable medical device industry has a growing need for miniaturised, long-life power sources to enable wireless data transfer from increasingly sophisticated devices that are improving patients' lives," explained Mike Nagy, chief technology officer of hemodynamic monitoring product producer Endotronix - a potential customer of the new technology.

Relative to standard lithium ion batteries, Stereax M50 solid-state batteries had up to five times longer life spans of up to 10 years, and up to 10 times lower leakage currents, which Ilika said made them suitable for low-power wireless charging.

They could also be integrated with other electronic components, enabling the end medical device to be kept as small as possible.

Stereax M50 yielded "leading edge" energy density, with 50% extra density compared to other commercially available solid-state batteries, it explained.

"The Stereax product family continues to grow, addressing a wide range of end applications. Medical applications are some of the most demanding environments for battery technology," said Ilika chief executive officer Graeme Purdy.

"The Stereax M50 is a smaller, safer and longer lasting battery, opening up the opportunities of life enhancing medical devices."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Ilika Market Data

Currency UK Pounds
Share Price 28.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 60.00
52 Week Low 27.00
Volume 51,260
Shares Issued 158.98m
Market Cap £45.31m

Ilika Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.17% below the market average28.17% below the market average28.17% below the market average28.17% below the market average28.17% below the market average
47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average
Price Trend
76.39% below the market average76.39% below the market average76.39% below the market average76.39% below the market average76.39% below the market average
64.1% below the sector average64.1% below the sector average64.1% below the sector average64.1% below the sector average64.1% below the sector average
Income Not Available
Growth
64.13% below the market average64.13% below the market average64.13% below the market average64.13% below the market average64.13% below the market average
52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Ilika Dividends

No dividends found

Trades for 16-Apr-2024

Time Volume / Share Price
16:29 3,030 @ 28.09p
16:17 1 @ 27.00p
16:17 2,422 @ 28.90p
16:06 1,555 @ 28.09p
13:21 170 @ 27.00p

Ilika Key Personnel

CEO Graeme Purdy
Chair Keith Jackson

Top of Page